+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Clinical Trial Equipment & Ancillary Solutions Market - Global Forecast 2026-2032- Product Image
Clinical Trial Equipment & Ancillary Solutions Market - Global Forecast 2026-2032- Product Image
New

Clinical Trial Equipment & Ancillary Solutions Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 193 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5612809
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The clinical trial equipment and ancillary solutions market is transforming rapidly as organizations adapt to digitalization, diverse trial models, and evolving compliance requirements. Strategic decision-makers require up-to-date insight into technological integration, procurement resilience, and regulatory shifts impacting operational performance and growth.

Market Snapshot: Clinical Trial Equipment & Ancillary Solutions Market

The Clinical Trial Equipment & Ancillary Solutions Market grew from USD 5.00 billion in 2025 to USD 5.46 billion in 2026. It is expected to continue growing at a CAGR of 10.05%, reaching USD 9.78 billion by 2032. This growth reflects the convergence of technology platforms, the evolution of decentralized and hybrid trial models, and a renewed focus on resilient, patient-centric operations across global clinical development.

Scope & Segmentation

This report covers the full spectrum of the clinical trial equipment and ancillary solutions market, framing drivers and barriers shaping organizational strategy.

  • Component Categories: Distinguishes between ancillary solutions—including laboratory services, patient engagement, and digital management systems—and physical equipment such as imaging devices, drug dispensing units, and monitoring tools.
  • Development Phases: Maps how early-phase, adaptive, and late-stage trials define procurement and deployment approaches for monitoring, data integration, and logistics platforms.
  • Therapeutic Areas: Addresses unique demands across cardiology, neurology, oncology, immunology, and infectious disease trials, highlighting technology needs and workflow differentiation.
  • End-User Types: Refines analysis for academic/research institutions, biotechnology firms, contract research organizations, medical device companies, and pharmaceutical manufacturers.
  • Regional Coverage: Evaluates mature and emerging regulatory and operational contexts across the Americas, Europe, Middle East, Africa, and Asia-Pacific, emphasizing clinical infrastructure, supply chain dynamics, and manufacturing diversity.
  • Technology Trends: Explores platforms for electronic data capture, remote monitoring, advanced analytics, and patient-centric engagement integrated with robust supply-chain and validation processes.

Key Takeaways for Senior Decision-Makers

  • Integrated digital platforms and interoperable tools are now central to operational efficiency, as sponsors deploy solutions that connect data capture, wearable monitoring, and imaging systems within core trial infrastructure.
  • Decentralized and hybrid trial models are expanding quickly, boosting demand for flexible remote monitoring and advanced biosample logistics while increasing the value of supply-chain resilience and last-mile fulfillment.
  • Vendor relationships are evolving as service providers and CROs expand via technology acquisitions and licensing, enabling modular, rapidly deployable solutions that meet increasingly specialized sponsor needs.
  • Patient-centric approaches, including real-world data collection and digital engagement, are redefining requirements for monitoring and biosample handling across therapeutic areas and trial phases.
  • Organizations are prioritizing sourcing frameworks that address operational risks and regulatory variability, ensuring qualification of suppliers across geographies to maintain trial timelines and compliance.

Tariff Impact on US Procurement and Supply Chain Strategy

The imposition of tariffs in the United States is prompting organizations to overhaul procurement, reevaluate sourcing relationships, and consider multi-sourcing or nearshoring. These pressures shift focus from price to resilience and total landed cost. Procurement leaders are adopting scenario planning and investing in supplier qualification, while service providers respond with bundled offerings to manage logistics and customs complexity. These adjustments are also accelerating investments in regional inventory buffering and supplier diversification.

Methodology & Data Sources

This study employs a mixed-methods approach—integrating qualitative interviews with sponsors, CROs, device manufacturers, and sites with secondary regulatory review, technical literature, and market mapping. The research team triangulated operational perspectives and thematic analysis to ensure a comprehensive synthesis of market drivers, procurement practices, and strategic responses.

Why This Report Matters

  • Guides executives in framing decisions for development, procurement, and supply chain design in the evolving clinical trial landscape.
  • Enables benchmarking of technology adoption, vendor specialization, and regional differentiation, supporting informed investment and sourcing strategy.
  • Offers a clear lens on regulatory and operational complexities, supporting risk mitigation and timeline preservation as therapeutic and trial models advance.

Conclusion

The clinical trial equipment and ancillary solutions market is at an inflection point as digital convergence, sourcing resilience, and patient-centered operations reshape the landscape. Strategic investments in integration, supplier networks, and modular technologies will help organizations accelerate development and sustain compliance in an increasingly complex environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Clinical Trial Equipment & Ancillary Solutions Market, by Component
8.1. Ancillary Solutions
8.1.1. Central Lab Services
8.1.2. Clinical Trial Management Systems (CTMS)
8.1.3. Data Management & Analytics Services
8.1.4. Electronic Data Capture (EDC) Systems
8.1.5. Interactive Response Technology (IRT)
8.1.6. Patient Engagement Solutions
8.1.7. Supply Chain & Logistics Solutions
8.2. Equipments
8.2.1. Drug Dispensing/Packaging Devices
8.2.2. Imaging Equipment
8.2.3. Laboratory Instruments
8.2.4. Monitoring Device
9. Clinical Trial Equipment & Ancillary Solutions Market, by Phase
9.1. Phase I
9.2. Phase II
9.3. Phase III
9.4. Phase IV
10. Clinical Trial Equipment & Ancillary Solutions Market, by Therapeutic Area
10.1. Cardiology
10.2. Immunology
10.3. Infectious Diseases
10.4. Neurology
10.5. Oncology
11. Clinical Trial Equipment & Ancillary Solutions Market, by End-User
11.1. Academic/Research Institutions
11.2. Biotechnology Firms
11.3. Contract Research Organizations (CROs)
11.4. Medical Device Companies
11.5. Pharmaceutical Companies
12. Clinical Trial Equipment & Ancillary Solutions Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Clinical Trial Equipment & Ancillary Solutions Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Clinical Trial Equipment & Ancillary Solutions Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Clinical Trial Equipment & Ancillary Solutions Market
16. China Clinical Trial Equipment & Ancillary Solutions Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Almac Group Limited
17.6. Ancillare, LP
17.7. Avantor, Inc.
17.8. Axelerist
17.9. B. Braun SE
17.10. Bio-Rad Laboratories, Inc.
17.11. Charles River Laboratories International, Inc.
17.12. Dassault Systèmes SE
17.13. Emsere B.V.
17.14. Eppendorf SE
17.15. Eurofins Scientific SE
17.16. Global Vision Technologies, Inc.
17.17. Hitachi, Ltd.
17.18. IQVIA Holdings Inc.
17.19. Lonza Group Ltd.
17.20. MedNet Solutions, Inc.
17.21. Myonex, Inc.
17.22. Oracle Corporation
17.23. Parexel International Corporation
17.24. Quanticate International Limited
17.25. Quipment SAS
17.26. Thermo Fisher Scientific, Inc.
17.27. United Parcel Service, Inc.
17.28. Veeva Systems Inc.
17.29. Yokogawa Electric Corporation
17.30. Zifo Technologies Private Limited
List of Figures
FIGURE 1. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CENTRAL LAB SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CENTRAL LAB SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CENTRAL LAB SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS), BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS), BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY DATA MANAGEMENT & ANALYTICS SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY DATA MANAGEMENT & ANALYTICS SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY DATA MANAGEMENT & ANALYTICS SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ELECTRONIC DATA CAPTURE (EDC) SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ELECTRONIC DATA CAPTURE (EDC) SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ELECTRONIC DATA CAPTURE (EDC) SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INTERACTIVE RESPONSE TECHNOLOGY (IRT), BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INTERACTIVE RESPONSE TECHNOLOGY (IRT), BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INTERACTIVE RESPONSE TECHNOLOGY (IRT), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PATIENT ENGAGEMENT SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PATIENT ENGAGEMENT SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PATIENT ENGAGEMENT SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SUPPLY CHAIN & LOGISTICS SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SUPPLY CHAIN & LOGISTICS SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SUPPLY CHAIN & LOGISTICS SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY DRUG DISPENSING/PACKAGING DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY DRUG DISPENSING/PACKAGING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY DRUG DISPENSING/PACKAGING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY IMAGING EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY IMAGING EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY IMAGING EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY LABORATORY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY LABORATORY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY LABORATORY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MONITORING DEVICE, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MONITORING DEVICE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MONITORING DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE I, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE I, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE I, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE II, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE II, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE II, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE III, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE III, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE III, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE IV, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE IV, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE IV, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY IMMUNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY IMMUNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ACADEMIC/RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ACADEMIC/RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ACADEMIC/RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 95. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 96. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2032 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 118. EUROPE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. EUROPE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 120. EUROPE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 121. EUROPE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2032 (USD MILLION)
TABLE 122. EUROPE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 123. EUROPE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 124. EUROPE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 125. MIDDLE EAST CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. MIDDLE EAST CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 127. MIDDLE EAST CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 128. MIDDLE EAST CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2032 (USD MILLION)
TABLE 129. MIDDLE EAST CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 130. MIDDLE EAST CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 132. AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 134. AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 135. AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2032 (USD MILLION)
TABLE 136. AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 137. AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 138. AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 141. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 147. ASEAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. ASEAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 149. ASEAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 150. ASEAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2032 (USD MILLION)
TABLE 151. ASEAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 152. ASEAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 153. ASEAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 154. GCC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. GCC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 156. GCC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 157. GCC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2032 (USD MILLION)
TABLE 158. GCC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 159. GCC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 160. GCC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 161. EUROPEAN UNION CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. EUROPEAN UNION CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 163. EUROPEAN UNION CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 164. EUROPEAN UNION CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2032 (USD MILLION)
TABLE 165. EUROPEAN UNION CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 166. EUROPEAN UNION CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 167. EUROPEAN UNION CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 168. BRICS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. BRICS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 170. BRICS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 171. BRICS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2032 (USD MILLION)
TABLE 172. BRICS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 173. BRICS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 174. BRICS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 175. G7 CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 176. G7 CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 177. G7 CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 178. G7 CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2032 (USD MILLION)
TABLE 179. G7 CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 180. G7 CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 181. G7 CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 182. NATO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. NATO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 184. NATO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 185. NATO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2032 (USD MILLION)
TABLE 186. NATO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 187. NATO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 188. NATO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 191. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 192. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 193. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2032 (USD MILLION)
TABLE 194. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 195. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 196. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 197. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 198. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 199. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 200. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2032 (USD MILLION)
TABLE 201. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 202. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 203. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Clinical Trial Equipment & Ancillary Solutions market report include:
  • Almac Group Limited
  • Ancillare, LP
  • Avantor, Inc.
  • Axelerist
  • B. Braun SE
  • Bio-Rad Laboratories, Inc.
  • Charles River Laboratories International, Inc.
  • Dassault Systèmes SE
  • Emsere B.V.
  • Eppendorf SE
  • Eurofins Scientific SE
  • Global Vision Technologies, Inc.
  • Hitachi, Ltd.
  • IQVIA Holdings Inc.
  • Lonza Group Ltd.
  • MedNet Solutions, Inc.
  • Myonex, Inc.
  • Oracle Corporation
  • Parexel International Corporation
  • Quanticate International Limited
  • Quipment SAS
  • Thermo Fisher Scientific, Inc.
  • United Parcel Service, Inc.
  • Veeva Systems Inc.
  • Yokogawa Electric Corporation
  • Zifo Technologies Private Limited

Table Information

Report AttributeDetails
No. of Pages193
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 5.46 Billion
Forecasted Market Value ( USD ) by 2032 $ 9.78 Billion
Compound Annual Growth Rate10.0%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Clinical Trials Market Forecast Report by Phase, Indication, Study Material, Country and Company 2025-2033 - Product Image

Clinical Trials Market Forecast Report by Phase, Indication, Study Material, Country and Company 2025-2033

  • Report
  • 220 Pages
  • Global
From
Clinical Trials Market in the US 2025-2029 - Product Image

Clinical Trials Market in the US 2025-2029

  • Report
  • 166 Pages
  • United States
From
North America Clinical Trials Market Size and Forecast Report 2025-2033 - Product Image

North America Clinical Trials Market Size and Forecast Report 2025-2033

  • Report
  • 200 Pages
  • North America
From
Non-Clinical Trials Market - Global Strategic Business Report - Product Image

Non-Clinical Trials Market - Global Strategic Business Report

  • Report
  • 485 Pages
  • Global
From
Clinical Trial Equipment and Ancillary Solutions - Global Strategic Business Report - Product Image

Clinical Trial Equipment and Ancillary Solutions - Global Strategic Business Report

  • Report
  • 285 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.